Pavco Pamela 4
4 · RXI PHARMACEUTICALS CORP · Filed Jan 20, 2009
Insider Transaction Report
Form 4
Pavco Pamela
VP of Pharmaceutical Devlpmt.
Transactions
- Award
Stock Option
2009-01-15+47,000→ 234,137 totalExercise: $4.19Exp: 2019-01-15→ Common Stock (47,000 underlying)
Footnotes (3)
- [F1]Granted pursuant to the RXi Pharmaceuticals Corporation 2007 Incentive Plan.
- [F2]Per share.
- [F3]2,937.5 of the options will vest on April 15, 2009 and the remaining shares will vest in equal installments on each of the next 15 quarterly anniversaries beginning on July 15, 2009.